Page 2889 - Cote clinical veterinary advisor dogs and cats 4th

1536 Boldface page numbers indicate chapter titles. Page numbers followed by a indicate algorithms; b, boxes; e, electronic content; f, figures; and t, tables.

Hematoma (Continued) Hepatic glycogen accumulation. See Vacuolar hepatopathy High-anion-gap metabolic acidosis, 15.e3, 314
renomegaly and, 879.e4 Hepatic injury, acute, 127, 442–444 High-flyer syndrome. See High-rise syndrome
thymic. See Thymic hemorrhage
High-rise syndrome, 469.e2–469.e4
Hepatic lipidosis, 444–446, 445.e1f, 1388
VetBooks.ir Hematopoiesis Hepatic macroabscess, 455 Himalayan cat
orofacial injuries, 469.e4–469.e5, 469.e5f
Hepatic microabscess, 455
canine cyclic, 195
cataracts in, 147
ineffective. See Myelodysplasia
Hepatic microvascular dysplasia, 655–656
Hematuria, 428–429, 1153, 1352
malignant, 446–448, 448.e1f
neonatal losses in, 687
causes of, 1229 Hepatic neoplasia corneal sequestration in, 208
urine discoloration and, 266.e5–266.e6 tumor types in, 1230 peritoneopericardial diaphragmatic hernia in, 778
Hemeralopia, 884 Hepatic nodules, benign, 449–450 polycystic kidney disease in, 805
Hemerocallis spp. toxicosis, 590 Hepatitis seborrhea oleosa in, 214
Hemichromes, 1335 chronic, of cocker spaniels, 450–452 urolithiasis in, 1014, 1016
Hemighost. See Eccentrocytes chronic idiopathic, of dogs, 452–454 Hindlimb nerves
Hemilaminectomy, for spinal cord neoplasia, 933 cirrhotic/fibrosing liver disease and, 174 cutaneous distribution of, 1257
Hemimandibulectomy, 713, 715 primary. See Cirrhotic/fibrosing liver disease spinal cord segment localization of, 1258
Hemivertebrae, 933.e2 Hepatization of the lung lobe, 594 Hindlimb paresis, 757–758, 1265–1266
Hemoabdomen, 430–431 Hepatobiliary cystadenoma, 232.e3–232.e4, 446–448 Hip dysplasia, 469–471, 471f, 723, 763, 1425a
Hemodialysis, 1120.e1–1120.e2 Hepatobiliary infections and abscesses, 455–456 Hip luxation, 472–473, 486.e1f
Hemoglobin, deoxygenated/reduced, 231. See also Hepatocellular carcinoma, 447 closed reduction of, 472, 1158–1159
Cyanosis Hepatocutaneous syndrome. See Superficial necrolytic Hip replacement, total, 470
Hemoglobin A1c. See Glycated hemoglobin dermatitis Hippuric acid crystals, 1290, 1332f
Hemoglobinuria, 1352 Hepatoid tumor. See Perianal adenoma/adenocarcinoma Hirschsprung disease, 202
urine discoloration and, 266.e6 Hepatomegaly, 456–458, 1231 Histamine-2 receptor blockers. See also specific drugs
Hemogram. See Complete blood count (CBC) Hepatopathy for esophageal perforation, 310
Hemolysis chronic, 452 for esophagitis, 313
in vitro, 1352–1353 copper-associated, 458–459 for gastric dilation/volvulus, 378
intravascular vs. extravascular, 61 in Labrador retrievers, 459–461 for gastric ulcer, 382
primary vs. secondary, 61 copper-storage Histiocytic diseases, 473–475
Hemolytic anemia, 59–60 cirrhotic/fibrosing liver disease and, 174 Histiocytic sarcoma, 473, 894.e1f, 932
causes of, 1197.e2 description of, 459 Histiocytoma, 893–894
hemotropic mycoplasmosis and, 438 reactive, 452 benign, 473
immune-mediated, 60–63, 62f, 62.e1f vacuolar, 1025–1027, 1027.e1f, 1231.e1 cutaneous, 230–231
Hemolytic-uremic syndrome, 431.e2–431.e3 Hepatoportal microvascular dysplasia. See Hepatic fibrous, ocular, 304
Hemoperitoneum, 430–431 microvascular dysplasia malignant fibrous, 616.e2–616.e3, 927
Hemophilia, 431–432, 431t Hepatosplenomegaly, 456–458 injection sites and, 550
A, 432 Hepatotoxicity Histiocytosis
C, 431t acetaminophen and, 11 cutaneous, 473
Hemoptysis, 432.e2–432.e3, 1229 blue-green algae and, 125.e2 malignant. See Histiocytic sarcoma
Hemorrhage, 433–435, 434f chemotherapy and, 153–154 systemic, 473
mediastinal, 640–642 mushrooms and, 666 Histopathology
nasal. See Epistaxis phenobarbital and, 303 in cutaneous neoplasia, 230
in sighthounds, 435–436 toxic agent list, 1231.e2 in osteosarcoma, 727
thymic, 973.e2 Hepatotoxins, 1231 in papillomatosis, 753
Hemorrhagic anemia. See Blood loss anemia Hepatozoon americanum, 461–462, 1172.e2t–1172.e3t, in pythiosis and lagenidiosis, 861
Hemorrhagic cystitis, chemotherapy and, 153–154 1320 in superficial necrolytic dermatitis, 952
Hemorrhagic diathesis. See Bleeding diatheses Hepatozoon canis, 461–462, 462.e1f, 1172.e2t–1172.e3t Histoplasma spp., 1320
Hemorrhagic disseminated intravascular coagulation, 270 Hepatozoon felis, 461–462 H. capsulatum, 476
Hemorrhagic gastroenteritis, 259 Hepatozoonosis, 461–462, 462.e1f Histoplasmosis, 476–477, 477.e1f, 725, 1157
Hemorrhagic nasal discharge. See Epistaxis Her2, 621 panniculitis and, 747
Hemorrheology, 433 Herbal drugs toxicosis, 462–464, 463t–464t Hit by car (HBC), 477–479, 1425a
Hemostatic defects. See also Bleeding diatheses Herbicide toxicosis, 464.e2–464.e3 Hock arthrocentesis, 1060f
hemorrhage and, 433 glyphosate, 392–393 Hock swelling, Shar-pei fever and, 908.e2
hemostatic test results in, 1202 paraquat and diquat, 756.e7–756.e8 HOD. See Hypertrophic osteodystrophy (HOD)
primary, 431, 433 Herding breeds, MDR1 mutation in, 638–639 Hollow point bullets, 400
secondary, 431, 433 Hereditary ataxia, 149.e3 Holter monitor
tests for. See Coagulation profile Hereditary defects. See also Congenital disorders; specific in arrhythmogenic right ventricular cardiomyopathy,
Hemothorax, 436–438, 791–793, 1230 defects 78
Hemotropic mycoplasmosis, 438–440, 439f coagulation factor deficiencies, 431–432, 431t in Chagas’ disease, 151
Heparin deafness, 237–238 in differentiation of syncope vs. seizure, 954
administration and dosage of, 1482 immunodeficiency syndromes, 530.e3–530.e4 in dilated cardiomyopathy, 264
for aortic thromboembolism, 76 platelet dysfunction and, 790.e5 procedure for, 1120–1122
for disseminated intravascular coagulation, 270 red blood cells, and hemolytic anemia, 59 in sick sinus syndrome, 916
for immune-mediated hemolytic anemia, 62 Hereditary footpad hyperkeratosis, 350 in Wolff–Parkinson-White syndrome, 1049.e3
low-molecular-weight Hernia Home-prepared diets, 479–480
administration and dosage of, 1482 diaphragmatic, 256–257, 1410.e1a nutritional secondary hyperparathyroidism and,
for disseminated intravascular coagulation, 270 hiatal, 468–469 697
for immune-mediated hemolytic anemia, 62 inguinal, 549–550 Hookworm infection, 480.e2–480.e3
for pulmonary thromboembolism, 843 paraesophageal, 468 Hops toxicosis, 480–481
for pulmonary thromboembolism, 843 perineal, 202, 774–776, 775f, 1439.e2a Hordeolum, 318
Hepatic abscess, 1230 peritoneopericardial, 778–779, 779f Hormonal disorders. See Endocrine disorders
Hepatic adenoma, 449–450 umbilical, 1003–1004 Hormone-responsive incontinence, 1011
Hepatic biopsy. See Liver biopsy Herniorrhaphy, 549–550 Hormone therapy, fetal adverse effects and, 818
Hepatic disorders. See also specific Liver entries Herpesviral keratitis, 464–466 Horner’s syndrome, 481.e2–481.e3, 481.e2f, 481.e3t,
acute abdomen and, 22 Herpesvirus. See Canine herpesvirus 1 (CHV-1); Feline 1232
multiple organ dysfunction syndrome and, 666 herpesvirus (FHV-1) pupil abnormalities and, 846–847
polyuria/polydipsia and, 813 Herpetic keratitis. See Herpesviral keratitis Hot spots. See Acute moist dermatitis
Hepatic encephalopathy, 440–442 Herplex. See Idoxuridine Hotz-Celsus procedure, 298
portosystemic shunt and, 815 Hespan. See Hetastarch Hounds
retention enema for, 1099 Hetastarch heart murmurs in, 413
treatment of, 175 administration and dosage of, 1482 Malassezia dermatitis in, 614. See also specific breeds
Hepatic failure for chronic idiopathic hepatitis, 453 House soiling. See Inappropriate elimination
acute/fulminant. See Hepatic injury, acute for head trauma, 405 Housebreaking problems. See Inappropriate elimination
drug interactions in, 175 Heterobilharzia americana, 901.e2 Household chemical toxicosis, 13–15, 178–179
Hepatic fibrosis, 174–176 Hiatal hernia, 312, 468–469 Housetraining, incomplete, 535
juvenile idiopathic, 174 High altitude, 748 Howell-Jolly bodies, 1353–1354
www.ExpertConsult.com